The Pharmacy and Poisons Board has said this due to the risks of compromising medication quality.
In July, PPB acquired the advanced Near Infrared (NIR) technology, the Pillscan, to strengthen its efforts in safeguarding drug quality in the country.
The intensified action follows a recent nationwide audit of
health facilities aimed at identifying and addressing malpractices within the
pharmaceutical sector.
Kaluai said the data gathered during the surveillance would
help pinpoint patterns in illegal pharmaceutical activities, enabling
intelligence-based enforcement to better target these issues.
He has called for collaboration between PPB and other
government agencies at border points to prevent the entry of unregistered
pharmaceuticals, further strengthening safeguards for public health.
“The PPB is urging the public to remain vigilant and report
any suspected illegal activities within the sector.”
Kaluai has reiterated the board’s commitment to reducing
health risks associated with medication errors due to non-compliant
distribution and transportation practices.
In July, PPB acquired the advanced Near Infrared (NIR)
technology, the Pillscan, to strengthen its efforts in safeguarding drug quality
in the country.
Provided by the Mission of Essential Medicines and Supplies,
the new tool is being used for on-site screening of medical products at PPB
regional offices and key entry points.
“By incorporating NIR technology into its operations, the
PPB aims to bolster its surveillance of the Kenyan pharmaceutical market and
protect public health.”
Currently, PPB randomly collects samples from all over the
country and analyses them at the National Quality Control Laboratory to test
for quality, safety and efficacy.